Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KRTAP4-8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PIK3CD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEMA5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRAPL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GEO DataSets Profile neighbors
TNXB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRUB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENOX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA1147 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMA8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMC8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORA17B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM108 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on